As of May 22
| -0.00028 / -0.77%|
The 1 analysts offering 12-month price forecasts for Amarantus Bioscience Holdings Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +24,744.72% increase from the last price of 0.04.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.